Skip to main content Skip to accessibility tools

Haematology Chemotherapy Protocols


Disclaimer:

The chemotherapy protocols available on this website are maintained by the Lancashire and South Cumbria Network Pharmacist David Barber. The Cancer Alliance is not responsible for the content or upkeep of the protocols. If you have any queries about the protocols please contact David Barber: Tel 01772 522339 or david.barber@lthtr.nhs.uk

Amyloidosis: Regimens for treating amyloidosis can be found on the National Amyloidosis Centre website

Protocols A-G

ABVD July 2019 Alemtuzumab v2 Ara C low dose v2 ATG ATRA Arsenic Azacitidine 5 day protocol (unlicensed) v1.0 2021-05-12 Azacitidine v2 BEACOPP escalated 2014 Benda R NHL Bendamustine Thalidomide Dexamethasone Bortezomib dexamethasone v2 Bosutinib Brentuximab Busulphan v2 C-Thal Dex Att v2 C-Thal Dex v2 Carfilzomib dexamethasone Chlorambucil v2 ChlVPP v2 Cladribine-Revised v2 CyBorDex Cyclo 1.5 Cyclo 3.0 Cyclo weekly v2 Dara-VTD for newly diagnosed myeloma eligible for PBSCT Feb 2022 Daratumumab Dasatinib v2 DECC Dexamethasone high dose v2 DexRC3 DT PACE 2 DVd protocol Final EPOCH R Etoposide 2 FC CLL4 v2 FC LY05 v2 FC R v2 Fludara v2 GDCVP v1 Gem Cis Dex GEM-P Gemcitabine v2

Protocols H-N

Hodgkins-MPM-Mar18 Hydroxycarbamide v2 Ibrutinib CLL Ibrutinib MCL Idarubicin dexamethasone Oct 2022 Idelalisib Rituximab v2 Imatinib v2 Ixazomib Lenalidomide & Dexamethasone Lenalidomide dexamethasone for myeloma Lenalidomide for MDS Lenalidomide Rituximab (Subcut) v1 2020-07-16 MATRIX v4 Melphalan and Predisolone Melphalan v2 Methotrexate High Dose Methylprednisolone HD v2 Modified R-CHOP-like Chemotherapy MRCHOP MTP Myeloma guideline draft for Network 2018 UPDATE Nilotinib v2 Nivolumab September 2022 NORDIC v2

Protocols O-Z

Cyclophos oral AIHA June 2021 Obinutuzumab and Bendamustine v1 - 2019-05 Obinutuzumab Chlorambucil Obinutuzumab CVP oral weekly mtx for CTCL December 2021 PAD bolus Panobinostat Bortezomib Dexamethasone PCNSDLBCL-Nov18 Pembrolizumab July 2022 Pembrolizumab_15 Pentostatin 2 Pixantrone Polatuzumab_Rituximab_Bendamustine Pomalidomide Ponatinib R-BAC(500) R-BAC(800) R-CODOX-M-over 65 v2 R-CODOX-M-under 65 v2 R-CVP 2 R-DHAP R-ICE Fractionated R-ICE v2 R-IVAC-over 65 R-IVAC-under 65 v2 RCD RCDa RCHOP-14 v2 RCHOP-21 v2 RGCVP v1 Ritux + cladribine for relapsed HCL v2 2022-01-05 Rituximab Bendamustine CLL Rituximab Chlorambucil CLL Rituximab Chlorambucil NHL Rituximab Gemcitabine v1 Rituximab Jan 2021 Rituximab Subcutaneous (Mabthera) Maintenance Rituximab Vel dex subcutaneous Rituximab Venetoclax Rsquared-Jan19-MPM Ruxolitinib Spanish AIDA Temzolomide_NHL Thalidomide v2 UKALL 14 Maintenance VCD sc VCD v2 VCD weekly Vel dex SUBCUTANEOUS Venetoclax VEPEM-B v2 VMP v1 VRCAP VTD 3 weekly v2 VTD 4 weekly VTD weekly Zanubrutinib protocol August 22
Return to header